Tag Archives: drugs
Welcome to “From the Archives,” a new Health Affairs Blog series, where we take a timely topic and delve into the literature and history, from a Health Affairs angle, of course. We recently published a Web First with results from a Kaiser Family Foundation (KFF) survey of employers, showing...
September 29, 2015
Although these laws have created an expectation that terminally ill patients will be able to quickly access potentially life-saving treatments by being exempted from the rules of the U.S. Food and Drug Administration (FDA), this expectation is, quite simply, false.
May 22, 2015
If there was ever a time for an informed discussion about the purpose and use of Risk Evaluation and Mitigation Strategies, it is now.
May 14, 2015
Indiana has recently become a place where health and politics intersect with striking consequences: One of the largest outbreaks of HIV ever identified in the U.S. continues to unfold in the state.
May 11, 2015
The past decade has seen a relatively constant rate of newly approved drugs every year. The number has even jumped in the past few years. Yet, despite such encouraging trends, we are actually facing a crisis in drug innovation today.
April 30, 2015
There is currently a much-needed national spotlight on the high rates of psychotropic medication use among children and youth in foster care, most of whom receive health coverage through Medicaid.
April 17, 2015
One critical incentive for ongoing drug discovery and development is the temporary monopoly pricing that manufacturers can command for novel drugs. Yet this incentive, embedded in current patent and regulatory policy, does not guarantee that manufacturers will deliver novel products with...
April 16, 2015